The aim of SYNERGY is to assess the effectiveness of synbiotics ( co-administration of pre - and probiotics ) as a potential treatment targeting the synthesis of uremic toxins , specifically , indoxyl sulphate ( IS ) and p-cresyl sulphate ( PCS ) .